医院环境中药物遗传检测的实施和评估策略:一个范围审查
Angela Wu1,2, Edward J Raack2,3, Colin J D Ross2,4
1Department of Experimental Medicine, University of British Columbia.
Therapeutic drug monitoring
|September 12, 2024
概括
药物遗传学测试可以提高药物的安全性和有效性. 本综述确定了临床药物遗传学计划的实施和评估策略,强调医生参与是将结果纳入实践的关键.
科学领域:
- 临床药理学 临床药理学
- 遗传学 是一个遗传学.
- 医疗保健管理的管理
背景情况:
- 药物遗传学测试在临床实践中提高了药物的安全性和有效性.
- 许多研究探讨了药物遗传学的实施,确定了障碍物和促进者.
- 在识别障碍/促进因素和开发药物遗传学测试临床策略之间存在差距.
研究的目的:
- 审查药物遗传学测试计划的实施和评估策略.
- 弥合所识别的障碍物和促进者以及临床反应策略之间的差距.
- 了解药物遗传学测试如何融入医院环境.
主要方法:
- 进行了符合PRISMA的范围审查.
- 研究的重点是医院环境中的药物遗传测试计划.
- 包括定量,定性和混合方法研究.
主要成果:
- 包括232项临床药物遗传计划研究.
- 精神病学 (26%) 和瘤学 (16%) 是主要的专业,有19%的机构课程.
- 医生参与对于将药物遗传学结果纳入临床决策至关重要,尽管提供方法各异.
结论:
- 需要进一步研究药物遗传学测试倡议的可持续性.
- 结果为跨专业的实施和评估策略提供了洞察力.
- 策略可以为改善临床药物遗传学测试的采用和有效性提供信息.
相关概念视频
Analysis of Population Pharmacokinetic Data
240
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
240
Pharmacokinetic Models: Comparison and Selection Criterion
50
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
50
Pharmacokinetic Models: Overview
618
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
618
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
64
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
64
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
51
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
51


